Company / EPS (Diluted)
Artiva Biotherapeutics, Inc. EPS (Diluted) History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$5.81
FY2025
5-year range
-$35.78 / -$5.81
FY2024-FY2025
Trend
+83.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-5.81 in FY2025.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 83.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.81 | +83.8% |
| FY2024 | -$35.78 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026